Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

15. July 2019 - 15:49 (CEST)

Chinese Patent Reexamination Department partially invalidates Epigenomics’ patent claims for Septin9

Read more

03. May 2019 - 0:40 (CEST)

CMS accepts Epigenomics’ application for NCD review

Read more

06. March 2019 - 20:57 (CEST)

Epigenomics AG terminates collaboration with Chinese licensing partner and announces anticipated revenue growth in 2019 outlook

Read more

Press releases

05. November 2019

Epigenomics AG: No operational reasons for sharp decline in share price

Read more

02. October 2019

Epigenomics AG: Results from Microsimulation Model to be presented at renowned health conference

Read more

07. August 2019

Epigenomics AG Highlights Operational Achievements and Reports Financial Results for First Six Months 2019

Read more